Elite in Retinal Artery Occlusion

Sven M. Poli

Hoppe Seyler Str. 3, 
Tuebingen, BW, DE 
Elite in Retinal Artery Occlusion
Hoppe Seyler Str. 3, 
Tuebingen, BW, DE 
OverviewLocationsClinical Research

Overview

Sven Poli practices in Tuebingen, Germany. Mr. Poli is rated as an Elite expert by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Retinal Artery Occlusion, Stroke, Mesenteric Venous Thrombosis, Thrombectomy, and Patent Foramen Ovale Repair.

His clinical research consists of co-authoring 190 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 27 articles in the study of Retinal Artery Occlusion.

Gender
Male

Locations

Hoppe Seyler Str. 3, Tuebingen, BW 72076, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation (ENRICH-AF)
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2025
Intervention Type: Drug, Other
Study Drug: Edoxaban
Study Phase: Phase 4
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Phase: Not Applicable
Apixaban for Treatment of Embolic Stroke of Undetermined Source (ATTICUS Randomized Trial)
Apixaban for Treatment of Embolic Stroke of Undetermined Source (ATTICUS Randomized Trial)
Enrollment Status: Completed
Publish Date: October 13, 2021
Intervention Type: Drug
Study Drugs: Apixaban, Aspirin
Study Phase: Phase 3
Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Phase II, Multicentre; Randomised, Dose-finding, Double-blind and Placebo Controlled Superiority Study With Parallel Groups
Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Phase II, Multicentre; Randomised, Dose-finding, Double-blind and Placebo Controlled Superiority Study With Parallel Groups
Enrollment Status: Completed
Publish Date: January 28, 2021
Intervention Type: Drug
Study Phase: Phase 2
Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III
Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III
Enrollment Status: Completed
Publish Date: September 27, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

190 Total Publications

Outcomes of Patent Foramen Ovale Closure in Patients Over 60 Years with Cryptogenic Stroke: A Systematic Review and Meta-Analysis.
Outcomes of Patent Foramen Ovale Closure in Patients Over 60 Years with Cryptogenic Stroke: A Systematic Review and Meta-Analysis.
Journal: International journal of stroke : official journal of the International Stroke Society
Published: October 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Poli's expertise for a condition
ConditionClose
View All 28 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile